SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients
CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices